Despite being home to the worldwide headquarters of vaccine maker Johnson & Johnson, and being nicknamed “The Healthcare City,” less than one-third of the New Brunswick’s eligible residents have received at least one dose of a COVID-19 vaccine.Continue Reading
The Acting FDA Commissioner told reporters that half a dozen “cases of a rare and severe type of blood clot” had occurred nationwide in women who were administered the Johnson & Johnson COVID-19 vaccine.Continue Reading
Widely viewed as potentially game-changing, a single-dose COVID-19 vaccine produced by Johnson & Johnson is on track to receive federal approval within weeks.Continue Reading
Robert Wood Johnson Hospital in New Brunswick is one of six hospitals throughout the state to receive the first batch of COVID-19 vaccinations.Continue Reading
TRENTON, NJ–On November 5, Governor Phil Murphy signed Executive Order 192, mandating safety requirements to protect workers from the COVID-19 pandemic in all New Jersey workplaces. The executive order isContinue Reading
In May, the New Brunswick-based corporation said it “will wind down the commercialization of talc-based Baby Powder in the US and Canada in the coming months,” adding that “existing inventory will continue to be sold through retailers until it runs out.” But that’s not enough, says “Black Women for Wellness,” one of the many advocacy groups pushing for J&J to stop selling its baby powder worldwide.Continue Reading
The President of the United States appears to have contracted the dreaded coronavirus and brought it with him to New Jersey.Continue Reading
